ArticleBriefings in bioinformatics2025
Evaluation of single-template ligand-based methods for the discovery of small-molecule nucleic acid binders.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Nucleic acid molecules, including ribonucleic acid (RNA) and deoxyribonucleic acid (DNA), are essential for various biological processes and can adopt diverse 3D structures that serve as potential drug targets. The direct targeting of nucleic acid structures by small molecules represents an emerging field in drug design with enormous potential for providing therapeutic options for diseases that are currently not addressed, including genetic diseases and viral infections. In the early days of this promising field, a shortage of reliable structural data presents a bottleneck to the direct adaptation of structure-based methods, making the simpler yet powerful ligand-based approach an attractive alternative for virtual screening. In this study, we thoroughly evaluate and benchmark these methods against the reported binding of small molecules to diverse nucleic acid targets. We also compare these methods with structure-based molecular docking. Our results demonstrate that classification performance is significantly influenced by the applied descriptors, the chosen similarity measure, and the specific nucleic acid target. We have also proposed a consensus method that combines the best-performing algorithms of distinct nature. According to our studies, this approach outperforms all other tested methods, providing a valuable framework for nucleic acid-targeted drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.